Lerfald, Maren
Lydersen, Stian
Zotcheva, Ekaterina
Nilsen, Tom I. L.
Eldholm, Rannveig S.
Martinez-Velilla, Nicolas
Selbæk, Geir
Ernstsen, Linda
Funding for this research was provided by:
the Liaison Committee for education, research, and innovation in Central Norway (2022-30545)
NTNU Norwegian University of Science and Technology
Article History
Received: 9 June 2023
Accepted: 21 September 2023
First Online: 2 October 2023
Declarations
:
: In all four surveys of the HUNT Study, participants gave informed written consent. The present study was approved by the Regional Committee of Medical and Health Research Ethics in Norway (REK sør-øst D 2017/382). Storage and use of data applies with the General Data Protection Regulation (GDPR).
: Not applicable.
: GS has participated in advisory board meetings for Roche and Biogen concerning treatment of dementia. No other conflicts of interest were reported.